Operating margin moved 146 bp higher
Operating margin changed +146 basis points from the comparable as-filed period.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Operating margin changed +146 basis points from the comparable as-filed period.
Operating cash flow / net income changed +120.4% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Operating income changed +12.2% from the comparable as-filed period.
Working capital changed -123.4% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
Operating cash-flow margin changed +1020 basis points from the comparable as-filed period.
Free-cash-flow margin changed +1075 basis points from the comparable as-filed period.
Gross margin changed +41 basis points from the comparable as-filed period.
Revenue changed +3.2% from the comparable as-filed period.
Net income changed +8.0% from the comparable as-filed period.
Inventory / revenue changed -96 basis points from the comparable as-filed period.
Cash & equivalents changed -8.8% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Capital expenditure changed -18.4% from the comparable as-filed period.
Capex / revenue changed -54 basis points from the comparable as-filed period.
Total assets changed -2.1% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
Stock-based compensation changed +16.0% from the comparable as-filed period.
Current assets changed -1.5% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes. This reverses 2 consecutive comparable moves in the opposite direction.
Trade receivables changed +3.6% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Cost of revenue changed +2.2% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
SBC / revenue changed +8 basis points from the comparable as-filed period.
Gross profit changed +4.0% from the comparable as-filed period.
Receivables / revenue changed +25 basis points from the comparable as-filed period.
Selling, general & administrative changed +3.8% from the comparable as-filed period.
Research & development changed +2.1% from the comparable as-filed period.
Working capital / assets changed -58 basis points from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
Current liabilities changed +1.0% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
R&D / revenue changed -3 basis points from the comparable as-filed period.
Current ratio changed -2.5% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
Inventory changed +1.2% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Gross margin changed -72 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Inventory / revenue changed -272 basis points from the comparable as-filed period.
Operating cash flow changed +10.8% from the comparable as-filed period.
Capital expenditure changed -27.3% from the comparable as-filed period.
Operating margin changed -35 basis points from the comparable as-filed period.
Receivables / revenue changed +189 basis points from the comparable as-filed period.
Revenue changed +3.0% from the comparable as-filed period.
Total assets changed -1.5% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes. This reverses 2 consecutive comparable moves in the opposite direction.
Net income changed +8.6% from the comparable as-filed period.
Free-cash-flow margin changed +189 basis points from the comparable as-filed period.
Operating income changed +1.0% from the comparable as-filed period.
Capex / revenue changed -67 basis points from the comparable as-filed period.
Shares outstanding changed +0.1% from the comparable as-filed period. The change ranks at the 33th percentile of 6 prior comparable changes.
Cost of revenue changed +4.8% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Trade receivables changed +6.2% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Working capital changed +123.9% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes. Relative percentage is de-emphasized because the comparison has a sign change.
Cash & equivalents changed +3.7% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Stock-based compensation changed -13.5% from the comparable as-filed period.
Operating cash-flow margin changed +122 basis points from the comparable as-filed period.
SBC / revenue changed -15 basis points from the comparable as-filed period.
Current assets changed +0.8% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Operating cash flow / net income changed +2.0% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Inventory changed -3.0% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
Research & development changed +3.3% from the comparable as-filed period.
Current liabilities changed -2.0% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Working capital / assets changed +61 basis points from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
Gross profit changed +1.8% from the comparable as-filed period.
Current ratio changed +2.8% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
Selling, general & administrative changed +2.2% from the comparable as-filed period.
R&D / revenue changed +1 basis points from the comparable as-filed period.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.